跳至主要内容
临床试验/IRCT20190819044563N1
IRCT20190819044563N1招募中3 期

Assessment the Effect of omega 3 supplementation on Improving Metabolic Syndrome indices in Patients with Ischemic heart disease

Oroumia University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Interested in attending the study who have completed and signed the informed consent form.
  • Metabolic syndrome according to existing criteria, including: There are 3 of the following: Waist circumference = 80 cm for women and Waist circumference = 94 cm for men, fasting blood glucose = 100 mg / dl , Systolic blood pressure = 130 and diastolic blood pressure above = 85 , mm Hg, HDL less than 50 mg / dL for women and less than 40 mg / dL for men and triglycerides; 150 mg / dL and drug administration for triglycerides Blood glyceride, cholesterol and LDL (including statins, etc.).
  • With ischemic heart disease.

排除标准

  • Mental, emotional, cognitive, or any disorders that may prevent a person from participating in this study.
  • People who have certain dietary restrictions and follow a specific diet.
  • autoimmune diseases (corticosteroids), cancer
  • alcohol consumption
  • Breastfeeding
  • Infectious Diseases
  • Chronic Kidney Disease
  • Liver disease
  • Food intolerance and sensitivity to fish
  • Anticoagulants such as warfarin
  • Changes in the level of physical activity during the study
  • People taking Omega-3 supplements
  • Consume more than one serving of fish per week
  • Omega-3 sensitivity cases

研究者

发起方
Oroumia University of Medical Sciences

相似试验

Assessment the Effect of omega 3 supplementation on... | 临床试验